daunorubicin has been researched along with Glomerulosclerosis, Focal Segmental in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, B; Yang, X; Zhang, C; Zhu, Z | 1 |
| Deng, AG; Li, N; Liu, JS; Lu, YH; Song, MN; Yang, X | 1 |
| Deng, A; Liu, J; Lu, Y; Yang, X; Zhu, Z | 1 |
3 other study(ies) available for daunorubicin and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
A Rho-kinase inhibitor, fasudil, attenuates progressive glomerulosclerosis induced by daunorubicin in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cyclin-Dependent Kinase Inhibitor p27; Daunorubicin; Glomerulosclerosis, Focal Segmental; Male; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; RNA, Messenger | 2009 |
Changes in angiopoietin expression in glomeruli involved in glomerulosclerosis in rats with daunorubicin-induced nephrosis.
Topics: Angiopoietin-1; Angiopoietin-2; Animals; Daunorubicin; Fibronectins; Glomerulosclerosis, Focal Segmental; Kidney Glomerulus; Male; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Tumor Necrosis Factor-alpha | 2006 |
A potential pathological role of angiopoietins expression in glomeruli during progressive glomerulisclerosis related to podocyte injury.
Topics: Angiopoietin-1; Angiopoietin-2; Animals; Daunorubicin; Disease Progression; Glomerulosclerosis, Focal Segmental; Immunohistochemistry; In Situ Hybridization; Kidney Glomerulus; Microscopy, Electron, Transmission; Nephrectomy; Podocytes; Random Allocation; Rats; Rats, Wistar; RNA, Messenger | 2006 |